Linde Announces 4,100% Cash Dividend

Industry: Energy & Power, Healthcare & Pharma, LNG
Company: Linde Bangladesh Limited
Company Intelligence Tag: Business Insights

Linde Bangladesh Ltd has declared a 4,100% cash dividend, the highest since its Dhaka Stock Exchange (DSE) listing. This follows a dramatic 4,596.5% increase in profit to Tk 631.68 crore as of July 31, 2024, compared to Tk 13.45 crore the previous year. The earnings per share (EPS) soared to Tk 415.08 from Tk 8.84, mainly due to a capital gain from selling shares of its subsidiary, Linde Industries Pvt Ltd. Net operating cash flow per share (NOCFPS) also rose to Tk 13.19 from Tk 8.38. Linde’s share price jumped 17.83% to Tk 1,547.30 after the dividend announcement.

Source for more details:

Related News

NWPGCL to Build Two Solar Plants with 140MW Capacity by 2026

May 14, 2025

North West Power Generation Company Ltd (NWPGCL) is set to boost Bangladesh's clean energy capacity by developing two new solar power plants with a combined output of 140 megawatts. The 80MW Padma Solar Power Plant will be located in Shariatpur and Madaripur

Govt to Buy Two LNG Cargoes from Vitol

May 12, 2025

The government of Bangladesh has approved the purchase of two LNG cargoes from Singapore's Vitol Asia Ltd through the spot market, with a total expenditure of Tk 1,104.41 crore—one cargo costing Tk 549.09 crore and the other Tk 555.32 crore.

IFC Injects 58M Dollars to Strengthen Renata

May 10, 2025

The International Finance Corporation (IFC) has committed a $58 million long-term loan to Renata PLC, a prominent pharmaceutical company in Bangladesh, to ease its working capital constraints amid US dollar liquidity challenges. The funding aims to stabilize Renata’s supply chain by enabling secure access to imported Active Pharmaceutical Ingredients (APIs), vital for uninterrupted medicine production.

ACI Logs Tk 13.69 Crore Loss In Q3 FY 2024–25

May 6, 2025

In Q3 of FY 2024–25, ACI Limited reported a consolidated loss of Tk 13.69 crore, a sharp decline from a Tk 1.65 crore profit in the same period last year, despite a 17% year-on-year revenue growth to Tk 3,573.50 crore.

Renata Profit Falls To Tk 58 Crore In Q3 FY 2024–25

May 6, 2025

In Q3 of FY 2024–25, Renata PLC’s profit fell 20% year-on-year to Tk 58 crore, despite a 16% rise in sales to Tk 1,070 crore, driven by strong domestic demand. However, profits declined due to a 100% surge in finance costs, reaching Tk 45 crore from Tk 23 crore, amid rising interest rates.

Square Pharma Profit Hits Tk 605 Crore In Q3 FY2024-25

May 4, 2025

In Q3 of FY2024-25, Square Pharmaceuticals reported an 18% year-on-year profit increase, reaching Tk 605 crore, while revenue rose 22% to Tk 2,012 crore. Its EPS climbed to Tk 6.83 from Tk 5.55, and for the July–March period, EPS reached Tk 21.15, up from Tk 18.24.

Related News

NWPGCL to Build Two Solar Plants with 140MW Capacity by 2026

May 14, 2025

North West Power Generation Company Ltd (NWPGCL) is set to boost Bangladesh's clean energy capacity by developing two new solar power plants with a combined output of 140 megawatts. The 80MW Padma Solar Power Plant will be located in Shariatpur and Madaripur

Govt to Buy Two LNG Cargoes from Vitol

May 12, 2025

The government of Bangladesh has approved the purchase of two LNG cargoes from Singapore's Vitol Asia Ltd through the spot market, with a total expenditure of Tk 1,104.41 crore—one cargo costing Tk 549.09 crore and the other Tk 555.32 crore.

IFC Injects 58M Dollars to Strengthen Renata

May 10, 2025

The International Finance Corporation (IFC) has committed a $58 million long-term loan to Renata PLC, a prominent pharmaceutical company in Bangladesh, to ease its working capital constraints amid US dollar liquidity challenges. The funding aims to stabilize Renata’s supply chain by enabling secure access to imported Active Pharmaceutical Ingredients (APIs), vital for uninterrupted medicine production.

ACI Logs Tk 13.69 Crore Loss In Q3 FY 2024–25

May 6, 2025

In Q3 of FY 2024–25, ACI Limited reported a consolidated loss of Tk 13.69 crore, a sharp decline from a Tk 1.65 crore profit in the same period last year, despite a 17% year-on-year revenue growth to Tk 3,573.50 crore.

Renata Profit Falls To Tk 58 Crore In Q3 FY 2024–25

May 6, 2025

In Q3 of FY 2024–25, Renata PLC’s profit fell 20% year-on-year to Tk 58 crore, despite a 16% rise in sales to Tk 1,070 crore, driven by strong domestic demand. However, profits declined due to a 100% surge in finance costs, reaching Tk 45 crore from Tk 23 crore, amid rising interest rates.

Square Pharma Profit Hits Tk 605 Crore In Q3 FY2024-25

May 4, 2025

In Q3 of FY2024-25, Square Pharmaceuticals reported an 18% year-on-year profit increase, reaching Tk 605 crore, while revenue rose 22% to Tk 2,012 crore. Its EPS climbed to Tk 6.83 from Tk 5.55, and for the July–March period, EPS reached Tk 21.15, up from Tk 18.24.

BUSINESSMONITOR

Connect with


Dont Have Account? Please register Here